SRSF2P1

Across TCGA pan-cancer cohorts, SRSF2P1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of SRSF2P1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where SRSF2P1 RNA is repressed in tumor relative to normal tissue. In most cancer types SRSF2P1 is over-expressed in tumor, although a few such as UCEC and BRCA show the opposite, repressed pattern.

UCEC, COAD, and BRCA are the cancer types where SRSF2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SRSF2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.153	.002	6	view →
COAD	All	All	+0.054	.025	2	view →
BRCA	Female	All	−0.014	.019	2	view →
READ	Female	All	−0.076	.049	1	view →
LUSC	All	All	+0.026	.042	1	view →
THCA	All	All	−0.023	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

SRSF2P1–UCEC

Open the UCEC breakdown →